Summary A revolutionary nanoneedle patch offers a painless alternative to traditional biopsies. This innovative technology uses microscopic needles to collect molecular data without tissue removal, enabling real-time disease monitoring and personalized medicine. The patch has […]
Summary The FDA approved Mavyret (glecaprevir/pibrentasvir) for acute hepatitis C in adults and children down to 3 years old. This marks the first approved DAA treatment for acute HCV, offering an 8-week regimen with a […]
Summary Scientists have developed a groundbreaking new biomarker for Parkinson’s disease. This new tool allows for early detection of the disease, even before symptoms appear. This discovery paves the way for earlier intervention and treatment, […]
Summary Cognito Therapeutics’ Spectris AD™ device uses light and sound stimulation to slow Alzheimer’s progression. A new study shows promising results, delaying cognitive decline, brain atrophy, and functional loss. This non-invasive therapy offers a potential […]
Summary Researchers have developed a new nanopore sequencing assay for identifying carriers of Fragile X syndrome (FXS), a leading cause of inherited intellectual disability. This faster, more efficient, and cost-effective method improves upon current screening […]
Summary Researchers at the Mayo Clinic have developed the world’s first biobank of salivary gland tissue, a major advancement in the fight against chronic dry mouth. This biobank offers hope for millions suffering from xerostomia, […]
Summary Cleveland Clinic pioneers the use of Glean, a wireless and catheter-free urodynamics system, improving patient comfort and data accuracy. Developed by Bright Uro, Glean addresses limitations of traditional methods, paving the way for better […]
Summary Dual-energy CT (DECT) is revolutionizing arthritis diagnosis and treatment. DECT scans offer superior accuracy in detecting inflammation, bone erosion, and crystal deposits compared to traditional imaging. This technology is improving diagnostic accuracy and changing […]
Summary A groundbreaking triple combination therapy offers new hope for glioblastoma patients, extending survival by up to 10 months. This approach combines Tumor Treating Fields (TTFields), immunotherapy, and chemotherapy to disrupt tumor growth and boost […]
Summary Jakob Just-Bomholt will become Elekta’s new President and CEO on September 1, 2025. He brings extensive international experience and a proven track record of driving profitable growth. This appointment signals a new chapter for […]
© 2025 Newsguru LTD. All rights reserved.